DCI Form 144 Filed for 100,500-Share Sale via Morgan Stanley (~$8.1M)
Rhea-AI Filing Summary
Form 144 notice filed relating to Donaldson Company, Inc. (DCI). The filer notified an intended sale of 100,500 common shares through Morgan Stanley Smith Barney LLC on 08/28/2025, with an aggregate market value listed at $8,101,998.45. The filing states these shares were acquired the same day (08/28/2025) by exercise of options under a registered plan and paid for in cash. The form also discloses prior sales by the same person, TOD CARPENTER, totaling 60,000 shares across three transactions on 07/08–07/10/2025 with gross proceeds shown as $4,293,449.22. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Compliance: Filing lodged as required under Rule 144, showing regulatory transparency
- Clear acquisition source: Shares acquired via exercise of options under a registered plan and paid in cash
Negative
- Sizeable insider sale: Intended disposition of 100,500 shares with an aggregate market value of $8,101,998.45
- Recent prior sales: Same individual sold 60,000 shares in July 2025 for gross proceeds of $4,293,449.22
Insights
TL;DR: Insider exercised options and plans a large sale of 100,500 DCI shares valued at ~$8.1M; prior July sales totaled 60,000 shares.
This Form 144 documents a planned disposition tied to option exercises under a registered plan, which indicates the shares were newly acquired and funded in cash on the same date. The use of a broker (Morgan Stanley Smith Barney LLC) and the filing of Form 144 reflect compliance with Rule 144 reporting requirements. The disclosed July transactions show prior partial monetization by the same seller for roughly $4.29M in gross proceeds. From a liquidity perspective, the filing signals a material individual sale but provides no information about company fundamentals or undisclosed material events.
TL;DR: This is a routine insider sale following option exercise; disclosure meets Rule 144 procedural requirements.
The notice identifies the transaction as an exercise under a registered plan and shows timely disclosure of an intended sale through an institutional broker. The signature attestations and representation about material non-public information are present, which is customary for fiduciary and compliance transparency. The filing does not indicate any unusual governance actions or changes in executive roles; it strictly documents transfer and sale activity by an individual.